comparemela.com

Carmelm Lynch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Adcendo Appoints Dominik Mumberg, PhD, as Chief Scientific Officer

/PRNewswire/ Adcendo ApS ("Adcendo"), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of.

Dominik mumbergCarmelm lynchMichael pehlDennis benjaminBayer agFinsen laboratoryUniversity of copenhagenUniversity of marburgApoptosis signal transduction research at scheringHead of therapeutic research area oncologyStanford executive programUniversity of chicagoNovo holdingsChief scientific officerTherapeutic research area oncologyTargeted alpha therapies

Adcendo Further Strengthens Management Team and Scientific Advisory Board with Appointment of International ADC Leaders

/PRNewswire/ Adcendo, a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the treatment of underserved cancers,.

Carmel lynchCarmelm lynchMichael pehlDennis benjaminBioinnovation instituteFinsen laboratoryUniversity of copenhagenPraecis pharmaceuticalsUniversity college dublinGlobal product developmentResearch at seattle geneticsCompany as researchHealth canadaNovo holdingsFred hutchinson cancer research centerNovo nordisk

Adcendo Further Strengthens Management Team and Scientific Advisory Board with Appointment of International ADC Leaders

- Building the team with experienced biotech experts and renowned leaders in the ADC field - Underscores company's commitment to progressing lead program on novel ADC target uPARAP COPENHAGEN

Carmel lynchPrnewswire adcendoCarmelm lynchMichael pehlDennis benjaminBioinnovation instituteFinsen laboratoryUniversity of copenhagenPraecis pharmaceuticalsUniversity college dublinGlobal product developmentResearch at seattle geneticsCompany as researchHealth canadaNovo holdingsFred hutchinson cancer research center

vimarsana © 2020. All Rights Reserved.